Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease
- PMID: 29677102
- PMCID: PMC6023281
- DOI: 10.3390/diseases6020028
Implications of PI3K/AKT/PTEN Signaling on Superoxide Dismutases Expression and in the Pathogenesis of Alzheimer's Disease
Abstract
Alzheimer’s disease is a neurodegenerative sickness, where the speed of personal disease progression differs prominently due to genetic and environmental factors such as life style. Alzheimer’s disease is described by the construction of neuronal plaques and neurofibrillary tangles composed of phosphorylated tau protein. Mitochondrial dysfunction may be a noticeable feature of Alzheimer’s disease and increased production of reactive oxygen species has long been described. Superoxide dismutases (SODs) protect from excess reactive oxygen species to form less reactive hydrogen peroxide. It is suggested that SODs can play a protective role in neurodegeneration. In addition, PI3K/AKT pathway has been shown to play a critical role on the neuroprotection and inhibiting apoptosis via the enhancing expression of the SODs. This pathway appears to be crucial in Alzheimer’s disease because it is related to the tau protein hyper-phosphorylation. Dietary supplementation of several ordinary compounds may provide a novel therapeutic approach to brain disorders by modulating the function of the PI3K/AKT pathway. Understanding these systems may offer a better efficacy of new therapeutic approaches. In this review, we summarize recent progresses on the involvement of the SODs and PI3K/AKT pathway in neuroprotective signaling against Alzheimer’s disease.
Keywords: AKT; Alzheimer’s disease; PI3K; PPAR; PTEN; n-3 PUFAs; reactive oxygen species; superoxide dismutase.
Conflict of interest statement
The authors declare that they have no competing financial interests.
Figures



Similar articles
-
Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer's disease.Alzheimers Res Ther. 2014 Jun 20;6(3):35. doi: 10.1186/alzrt265. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25031641 Free PMC article. Review.
-
Isoforsythiaside Attenuates Alzheimer's Disease via Regulating Mitochondrial Function Through the PI3K/AKT Pathway.Int J Mol Sci. 2020 Aug 8;21(16):5687. doi: 10.3390/ijms21165687. Int J Mol Sci. 2020. PMID: 32784451 Free PMC article.
-
A hypothetic role of minocycline as a neuroprotective agent against methylphenidate-induced neuronal mitochondrial dysfunction and tau protein hyper-phosphorylation: Possible role of PI3/Akt/GSK3β signaling pathway.Med Hypotheses. 2019 Jul;128:6-10. doi: 10.1016/j.mehy.2019.04.017. Epub 2019 Apr 24. Med Hypotheses. 2019. PMID: 31203911
-
Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.Mol Neurobiol. 2018 Jul;55(7):6076-6093. doi: 10.1007/s12035-017-0798-6. Epub 2017 Nov 23. Mol Neurobiol. 2018. PMID: 29170981
-
Diets involved in PPAR and PI3K/AKT/PTEN pathway may contribute to neuroprotection in a traumatic brain injury.Alzheimers Res Ther. 2013 Sep 26;5(5):42. doi: 10.1186/alzrt208. eCollection 2013. Alzheimers Res Ther. 2013. PMID: 24074163 Free PMC article. Review.
Cited by
-
PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease.Front Pharmacol. 2021 Apr 15;12:648636. doi: 10.3389/fphar.2021.648636. eCollection 2021. Front Pharmacol. 2021. PMID: 33935751 Free PMC article. Review.
-
The Chemopreventive Effects of Chlorogenic Acids, Phenolic Compounds in Coffee, against Inflammation, Cancer, and Neurological Diseases.Molecules. 2023 Mar 4;28(5):2381. doi: 10.3390/molecules28052381. Molecules. 2023. PMID: 36903626 Free PMC article. Review.
-
Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses.Diseases. 2019 Feb 13;7(1):22. doi: 10.3390/diseases7010022. Diseases. 2019. PMID: 30781836 Free PMC article. Review.
-
Targeting of the PI3 K/AKT/GSK3β Pathway in Parkinson's Disease: A Therapeutic Blueprint.Mol Neurobiol. 2025 Jun 5. doi: 10.1007/s12035-025-05113-y. Online ahead of print. Mol Neurobiol. 2025. PMID: 40474025 Review.
-
Insights on the Characteristics and Therapeutic Potential of Mesenchymal Stem Cell-derived Exosomes for Mitigation of Alzheimer's Disease's Pathogenicity: A Systematic Review.Cell Biochem Biophys. 2025 Jun;83(2):1399-1414. doi: 10.1007/s12013-024-01598-x. Epub 2024 Oct 22. Cell Biochem Biophys. 2025. PMID: 39436580
References
-
- Mathys Z.K., White A.R. Copper and Alzheimer’s Disease. Adv. Neurobiol. 2017;18:199–216. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials